Infectocipro (Ciprofloxacin Hydrochloride Monohydrate)

Ciprofloxacin, the active ingredient in Infectocipro, is a fluoroquinolone antibiotic presented as a topical ear preparation for auricular use. It treats bacterial ear infections such as otitis externa in patients requiring localized therapy.

GNH USA supplies Infectocipro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infectocipro is a fluoroquinolone antibiotic indicated for bacterial ear conditions. It is applied directly to the external auditory canal to eradicate pathogens.

- Otitis externa: reduces bacterial load and alleviates inflammation in the outer ear canal. - Acute bacterial ear canal infection: provides rapid antibacterial activity to control infection. - Chronic otitis externa: helps eradicate resistant organisms and prevent recurrence.

Common Side Effects: - Ear irritation: mild burning or stinging sensation at the application site. - Itching: localized pruritus within the ear canal. - Temporary hearing changes: transient muffled hearing after dosing. - Redness: mild erythema of the external ear. - Discharge: watery or serous ear fluid. - Local pain: mild discomfort during or after application.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Ototoxicity: potential hearing loss or vestibular dysfunction with extensive exposure. - Severe vestibular disturbance: dizziness or vertigo. - Stevens‑Johnson syndrome: rare severe skin reaction. - Tendon rupture: systemic exposure may increase risk of tendon injury. - Severe local infection: worsening of ear infection despite therapy.

Infectocipro should be used with caution and according to professional guidance. - Allergy assessment: avoid if the patient has known hypersensitivity to fluoroquinolones. - Ear condition: confirm an intact tympanic membrane before administration. - Age considerations: use carefully in pediatric patients; dosage may differ. - Concurrent ototoxic drugs: monitor for additive ear toxicity when used with other ototoxic agents. - Pregnancy and lactation: consult a healthcare professional before use. - Store at below 25°C: keep in the original container, protect from moisture and light.

Infectocipro may interact with other medicines; monitoring is advised.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use can increase risk of systemic toxicity. - Corticosteroid ear drops: may heighten local irritation. - Antacids containing aluminum or magnesium: can reduce systemic absorption if systemic exposure occurs.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: monitor for tendon injury risk. - Warfarin: observe INR values if systemic absorption is suspected. - Diabetes medications: watch for altered blood glucose control.